Search

Andries Rachel Zijlstra

from Alameda, CA
Age ~52

Andries Zijlstra Phones & Addresses

  • Alameda, CA
  • Shelton, WA
  • 3551 Redwood St, San Diego, CA 92104 (360) 481-1405
  • 1015 Villa Pl, Nashville, TN 37212
  • Rochester, WA
  • Pullman, WA
  • Moses Lake, WA
  • 3551 Redwood St, San Diego, CA 92104

Publications

Us Patents

Stage Adaptor For Imaging Biological Specimens

View page
US Patent:
20130002848, Jan 3, 2013
Filed:
Jan 14, 2011
Appl. No.:
13/522448
Inventors:
Andries Zijlstra - Nashville TN, US
John Lewis - London, CA
Assignee:
INNOVASCREEN Inc - New Glasgow
International Classification:
G02B 21/34
H04N 7/18
US Classification:
348 80, 359398, 348E07085
Abstract:
A stage adaptor for imaging a biological specimen is described. The adaptor having a housing; a vented chamber contained within the housing; and a removable lid for covering the vented chamber. A depression is provided on the removable lid for receiving an objective from a microscope. An aperture is also provided at the apex of the depression for viewing inside the vented chamber. Also described is an integrated stage adaptor and imaging system as well as a method for imaging the biological specimen using the stage adaptor.

Magnetic Reversibly Attached Template (Mrat) And Uses Therefor

View page
US Patent:
20120299221, Nov 29, 2012
Filed:
Dec 2, 2010
Appl. No.:
13/513785
Inventors:
Andries Zijlstra - Nashville TN, US
William Ashby - Nashville TN, US
John Wikswo - Brentwood TN, US
Philip Samson - Nashville TN, US
Assignee:
VANDERBILT UNIVERSITY - Nashville TN
International Classification:
B29C 67/24
C23C 14/28
US Classification:
264437, 425 3
Abstract:
The magnetic reversibly attached template (MRAT) are solid devices made of biocompatible material containing a magnetic material. These devices can be made in any shape using microfabrication, milling, and molding and can be positioned and secured using magnetic forces. The applications of the M RAT encompass the patterning of biological and non-biological materials including cells, nucleic acids, peptides, proteins, aqueous solutions, polymers, rubbers, and other reagents on solid surfaces.

Palmitoyl Protein Biomarkers In Purified Extracellular Vesicles For Early Identification Of Clinically Significant Prostate Cancer

View page
US Patent:
20200408766, Dec 31, 2020
Filed:
Jul 6, 2020
Appl. No.:
16/921646
Inventors:
- Los Angeles CA, US
- Nashville TN, US
Javier Mariscal Avila - Los Angeles CA, US
Tatyana Vagner - Los Angeles CA, US
Sungyong You - Los Angeles CA, US
Andries Zijlstra - Nashville TN, US
Assignee:
CEDARS-SINAI MEDICAL CENTER - Los Angeles CA
Vanderbilt University - Nashville TN
International Classification:
G01N 33/574
G01N 33/68
Abstract:
The invention provides for methods for isolating large EVs and detecting palmitoyl proteins in the large EVs, as well as methods for detecting clinically significant prostate cancer based on the presence of palmitoyl proteins in the isolated large EVs in a subject in need thereof. The method further comprises administering cancer therapy to the subject.
Andries Rachel Zijlstra from Alameda, CA, age ~52 Get Report